Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma

S. Lewin, D. Dezube, A. K. Guddati, K. Mittal, F. Muggia, Paula Klein

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Hypercalcemia has been reported in association with a number of malignancies, but it is an unusual manifestation of ovarian cancer. This finding at presentation (possibly aggravated by oral calcium intake) led to discovery of a clear cell carcinoma of the ovary. The implications and pathophysiology of this association are reviewed. Case report: Following presentation with abdominal symptoms, this premenopausal woman was found to have bilateral adnexal masses and hypercalcemia. Her parathormone-related polypeptide was found to be elevated. After surgery and staging, she received adjuvant carboplatin and paclitaxel (later substituted by docetaxel). She has done well on her long-term follow-up. Conclusions: This rare paraneoplastic manifestation of ovarian cancer may be associated with long-term survival if discovered at an early stage. In this instance, further benefit may have been obtained from adjuvant platinum-based chemotherapy. Copyright:

Original languageEnglish (US)
Article number271
Journalecancermedicalscience
Volume6
Issue number1
DOIs
StatePublished - Oct 2 2012

Fingerprint

Clear Cell Adenocarcinoma
Hypercalcemia
docetaxel
Ovarian Neoplasms
Carboplatin
Paclitaxel
Platinum
Parathyroid Hormone
Ovary
Calcium
Carcinoma
Drug Therapy
Peptides
Survival
Neoplasms

Keywords

  • Clear cell adenocarcinoma
  • Hypercalcemia
  • Ovarian
  • PTHrP
  • Paraneoplastic

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma. / Lewin, S.; Dezube, D.; Guddati, A. K.; Mittal, K.; Muggia, F.; Klein, Paula.

In: ecancermedicalscience, Vol. 6, No. 1, 271, 02.10.2012.

Research output: Contribution to journalArticle

Lewin, S. ; Dezube, D. ; Guddati, A. K. ; Mittal, K. ; Muggia, F. ; Klein, Paula. / Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma. In: ecancermedicalscience. 2012 ; Vol. 6, No. 1.
@article{5fd000f0ec1847bea2a3fb88367774f7,
title = "Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma",
abstract = "Background: Hypercalcemia has been reported in association with a number of malignancies, but it is an unusual manifestation of ovarian cancer. This finding at presentation (possibly aggravated by oral calcium intake) led to discovery of a clear cell carcinoma of the ovary. The implications and pathophysiology of this association are reviewed. Case report: Following presentation with abdominal symptoms, this premenopausal woman was found to have bilateral adnexal masses and hypercalcemia. Her parathormone-related polypeptide was found to be elevated. After surgery and staging, she received adjuvant carboplatin and paclitaxel (later substituted by docetaxel). She has done well on her long-term follow-up. Conclusions: This rare paraneoplastic manifestation of ovarian cancer may be associated with long-term survival if discovered at an early stage. In this instance, further benefit may have been obtained from adjuvant platinum-based chemotherapy. Copyright:",
keywords = "Clear cell adenocarcinoma, Hypercalcemia, Ovarian, PTHrP, Paraneoplastic",
author = "S. Lewin and D. Dezube and Guddati, {A. K.} and K. Mittal and F. Muggia and Paula Klein",
year = "2012",
month = "10",
day = "2",
doi = "10.3332/ecancer.2012.271",
language = "English (US)",
volume = "6",
journal = "ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intellilgence",
number = "1",

}

TY - JOUR

T1 - Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma

AU - Lewin, S.

AU - Dezube, D.

AU - Guddati, A. K.

AU - Mittal, K.

AU - Muggia, F.

AU - Klein, Paula

PY - 2012/10/2

Y1 - 2012/10/2

N2 - Background: Hypercalcemia has been reported in association with a number of malignancies, but it is an unusual manifestation of ovarian cancer. This finding at presentation (possibly aggravated by oral calcium intake) led to discovery of a clear cell carcinoma of the ovary. The implications and pathophysiology of this association are reviewed. Case report: Following presentation with abdominal symptoms, this premenopausal woman was found to have bilateral adnexal masses and hypercalcemia. Her parathormone-related polypeptide was found to be elevated. After surgery and staging, she received adjuvant carboplatin and paclitaxel (later substituted by docetaxel). She has done well on her long-term follow-up. Conclusions: This rare paraneoplastic manifestation of ovarian cancer may be associated with long-term survival if discovered at an early stage. In this instance, further benefit may have been obtained from adjuvant platinum-based chemotherapy. Copyright:

AB - Background: Hypercalcemia has been reported in association with a number of malignancies, but it is an unusual manifestation of ovarian cancer. This finding at presentation (possibly aggravated by oral calcium intake) led to discovery of a clear cell carcinoma of the ovary. The implications and pathophysiology of this association are reviewed. Case report: Following presentation with abdominal symptoms, this premenopausal woman was found to have bilateral adnexal masses and hypercalcemia. Her parathormone-related polypeptide was found to be elevated. After surgery and staging, she received adjuvant carboplatin and paclitaxel (later substituted by docetaxel). She has done well on her long-term follow-up. Conclusions: This rare paraneoplastic manifestation of ovarian cancer may be associated with long-term survival if discovered at an early stage. In this instance, further benefit may have been obtained from adjuvant platinum-based chemotherapy. Copyright:

KW - Clear cell adenocarcinoma

KW - Hypercalcemia

KW - Ovarian

KW - PTHrP

KW - Paraneoplastic

UR - http://www.scopus.com/inward/record.url?scp=84869445161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869445161&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2012.271

DO - 10.3332/ecancer.2012.271

M3 - Article

C2 - 23056149

AN - SCOPUS:84869445161

VL - 6

JO - ecancermedicalscience

JF - ecancermedicalscience

SN - 1754-6605

IS - 1

M1 - 271

ER -